IBB: 生物科技指数ETF-iShares Nasdaq

IBB新闻

• 07:35 The Steepener Was Built On A Barrel Of Oil
• 17:03 AI Bubble Risks Make Dividend Stocks Attractive Again
• 12:30 XLV: Healthcare Sector On The Mend, But Probably Not For Long (NYSEARCA:XLV)
• 05:20 This Week's Market Wrap: AI Shakeup, Earnings, And Renewed Oil Shock
• 16:30 Where To Invest Now In AI, Biotech, Small Caps, And Gold
• 12:50 The Next Big Theme: July 2026
• 11:03 This Wall Street ‘theme-o-meter’ has a clear message: The artificial-intelligence bull market is back
• 03:45 Equity Outlook Q3 2026: Broadening Earnings Growth Meets Elevated Volatility
• 19:06 SELLAS: Imminent Catalyst, Dual-Platform Pipeline, And A Market That Hasn't Caught Up
• 15:35 It's Not All About AI: Where To Find Other Potential Market Opportunities
• 00:00 Global Markets: Fundamentals Have The Floor
• 06:30 Healthcare Investing: Finding Growth Beyond Pharmaceuticals
• 14:28 SBIO: Biotech Breakthrough Opportunities Screened For Cash Burn (NYSEARCA:SBIO)
• 08:54 The chip pullback is ushering in a bumpy market. These sectors are the best bets now, according to Morgan Stanley.
• 15:35 The Week The AI Trade Broke, And Why The Data Says 'Rotation,' Not 'Recession'
• 07:20 America At 250: Built On Reinvention, Powered By Innovation
• 21:20 Biotech Is The Rate Cut Trade In Disguise
• 21:00 Big Pharma's Looming Patent Cliff Period And How It Is Trying To Address It (NYSEARCA:XLV)
• 10:20 Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
• 10:16 Weekly Market Pulse: It's An AI Stock World
• 13:38 Stock Market Week Ahead: Rotating, For Now, Away From The AI Boom
• 08:28 Zacks Investment Ideas feature highlights: IBB, Novartis, Pfizer and Eli Lilly's
• 20:17 Biotech's Silent Resurgence (5-Year Base Breakout)
• 18:50 Healthcare's Quiet Comeback: Innovation, Obesity Drugs And New Opportunities